CareDx, Inc. (CDNA) financial statements (2021 and earlier)
Company profile
| Business Address |
1 TOWER PLACE SOUTH SAN FRANCISCO, CA 94080 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| SIC | 8071 - Medical Laboratories (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments, including: | 225 | 38 | 65 | 17 | 17 | 30 | 36 | ||
| Cash and cash equivalents | 135 | 38 | 65 | 17 | 17 | 30 | 36 | ||
| Short-term investments | 90 | ||||||||
| Other undisclosed cash, cash equivalents, and short-term investments | (0) | ||||||||
| Receivables | 35 | 24 | 10 | 3 | |||||
| Inventory, net of allowances, customer advances and progress billings | 10 | 6 | 5 | 6 | 5 | 1 | 1 | ||
| Inventory | 10 | 6 | 5 | 6 | 5 | 1 | 1 | ||
| Other undisclosed current assets | 4 | 4 | 2 | 1 | 4 | 4 | 3 | ||
| Total current assets: | 273 | 72 | 81 | 27 | 27 | 34 | 40 | ||
| Noncurrent Assets | |||||||||
| Operating lease, right-of-use asset | 15 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Property, plant and equipment | 11 | 4 | 4 | 2 | 3 | 2 | 2 | ||
| Intangible assets, net (including goodwill) | 68 | 69 | 45 | 45 | 47 | 19 | 19 | ||
| Goodwill | 24 | 24 | 12 | 12 | 14 | 12 | 12 | ||
| Intangible assets, net (excluding goodwill) | 44 | 46 | 33 | 33 | 33 | 7 | 7 | ||
| Restricted cash and investments | 0 | 0 | 0 | 10 | |||||
| Other noncurrent assets | 1 | 1 | 0 | 0 | 0 | ||||
| Other undisclosed noncurrent assets | 5 | 0 | 0 | 0 | |||||
| Total noncurrent assets: | 95 | 80 | 50 | 57 | 50 | 21 | 21 | ||
| TOTAL ASSETS: | 369 | 152 | 131 | 84 | 77 | 56 | 61 | ||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 33 | 21 | 16 | 9 | 9 | 5 | 4 | ||
| Accounts payable | 10 | 6 | 5 | 3 | 3 | 2 | 1 | ||
| Accrued liabilities | 5 | 3 | 2 | 1 | 1 | 1 | 1 | ||
| Employee-related liabilities | 18 | 12 | 9 | 5 | 4 | 2 | 2 | ||
| Interest and dividends payable | 0 | 1 | |||||||
| Deferred revenue | 4 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Debt | 0 | 16 | 23 | 3 | 6 | ||||
| Deferred rent credit | 0 | ✕ | ✕ | ✕ | ✕ | ||||
| Derivative instruments and hedges, liabilities | 15 | ||||||||
| Business combination, contingent consideration, liability | 1 | 1 | |||||||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 0 | 0 | 0 | 1 | ||
| Contract with customer, liability | ✕ | 4 | ✕ | ✕ | ✕ | ✕ | |||
| Other undisclosed current liabilities | 32 | 9 | 3 | 3 | 8 | 1 | 1 | ||
| Total current liabilities: | 69 | 35 | 20 | 43 | 41 | 10 | 11 | ||
| Noncurrent Liabilities | |||||||||
| Long-term debt and lease obligation | 16 | 0 | 18 | 1 | 13 | 6 | |||
| Long-term debt, excluding current maturities | 18 | 1 | 13 | 5 | |||||
| Capital lease obligations | ✕ | ✕ | 0 | 0 | 0 | 0 | |||
| Operating lease, liability | 16 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Liabilities, other than long-term debt | 2 | 4 | 5 | 10 | 10 | 3 | 3 | ||
| Deferred revenue and credits | ✕ | ✕ | ✕ | 2 | 2 | 2 | 2 | ||
| Deferred rent credit | 0 | ✕ | ✕ | ✕ | ✕ | ||||
| Deferred tax liabilities, net | ✕ | ✕ | 3 | 5 | 6 | ||||
| Deferred income tax liabilities | 1 | ✕ | ✕ | ✕ | ✕ | ✕ | |||
| Other liabilities | 0 | 4 | 1 | 1 | 1 | 0 | 0 | ||
| Business combination, contingent consideration, liability | 2 | 0 | 1 | 1 | |||||
| Other undisclosed noncurrent liabilities | 4 | 14 | 10 | 19 | 5 | (0) | |||
| Total noncurrent liabilities: | 22 | 18 | 15 | 47 | 16 | 16 | 9 | ||
| Total liabilities: | 91 | 53 | 35 | 90 | 57 | 26 | 20 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | 278 | 99 | 96 | (6) | 19 | 29 | 41 | ||
| Common stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Additional paid in capital | 632 | 438 | 412 | 264 | 236 | 203 | 201 | ||
| Accumulated other comprehensive loss | (2) | (5) | (4) | (2) | (4) | ||||
| Accumulated deficit | (353) | (334) | (312) | (268) | (213) | (173) | (159) | ||
| Warrants and rights outstanding | 19 | ||||||||
| Other undisclosed stockholders' equity attributable to parent | (19) | ||||||||
| Stockholders' equity attributable to noncontrolling interest | 0 | 0 | |||||||
| Total stockholders' equity: | 278 | 99 | 96 | (6) | 20 | 29 | 41 | ||
| TOTAL LIABILITIES AND EQUITY: | 369 | 152 | 131 | 84 | 77 | 56 | 61 | ||
Income statement (P&L) ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Revenues | 192 | 127 | 77 | 48 | 41 | 28 | 27 | |
| Revenue, net | ✕ | ✕ | ✕ | 48 | 40 | 28 | 27 | |
| Cost of revenue | (45) | (0) | (9) | (10) | (10) | (9) | ||
| Cost of goods and services sold | (0) | (9) | (10) | (10) | (9) | |||
| Gross profit: | 192 | 82 | 76 | 39 | 30 | 18 | 19 | |
| Operating expenses | (215) | (106) | (92) | (69) | (78) | (40) | (26) | |
| Other undisclosed operating income | 0 | 9 | 10 | 10 | 9 | |||
| Operating income (loss): | (23) | (25) | (16) | (20) | (37) | (12) | 1 | |
| Nonoperating income (expense) | 3 | 1 | (0) | (1) | (2) | (0) | 0 | |
| Other nonoperating income (expense) | (1) | (1) | (0) | (1) | (2) | (0) | 0 | |
| Interest and debt expense | (0) | |||||||
| Income (loss) from continuing operations before equity method investments, income taxes: | (20) | (24) | (16) | (22) | (39) | (12) | 1 | |
| Other undisclosed loss from continuing operations before income taxes | (32) | (35) | (2) | (2) | (2) | |||
| Loss from continuing operations before income taxes: | (20) | (24) | (48) | (57) | (41) | (14) | (1) | |
| Income tax benefit | 1 | 2 | 1 | 2 | 2 | 2 | ||
| Net income (loss): | (19) | (22) | (47) | (56) | (40) | (14) | 1 | |
| Net income attributable to noncontrolling interest | 0 | 0 | 0 | |||||
| Net income (loss) available to common stockholders, basic: | (19) | (22) | (47) | (55) | (39) | (14) | 1 | |
| Interest on convertible debt | 0 | |||||||
| Other undisclosed net loss available to common stockholders, diluted | (0) | |||||||
| Net income (loss) available to common stockholders, diluted: | (19) | (22) | (47) | (55) | (39) | (14) | 1 | |
Comprehensive Income ($ in millions)
| 12/31/2020 | 12/31/2019 | 12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | 12/31/2014 | ||
|---|---|---|---|---|---|---|---|---|
| Net income (loss): | (19) | (22) | (47) | (56) | (40) | (14) | 1 | |
| Other undisclosed comprehensive income (loss) | 3 | (1) | (2) | 1 | (4) | |||
| Comprehensive income (loss): | (16) | (23) | (49) | (54) | (43) | (14) | 1 | |
| Comprehensive income, net of tax, attributable to noncontrolling interest | 0 | 0 | 0 | |||||
| Comprehensive income (loss), net of tax, attributable to parent: | (16) | (23) | (49) | (54) | (43) | (14) | 1 | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.